- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-01-0012165

About Domagk Smith Laboratories Private Limited
Data last updated:
Domagk Smith Laboratories Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 January 2001 and has been in existence for over 25 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL2001PTC109384. Its GSTIN is 06AABCD7644M1ZD (Haryana).
The company has an authorised share capital of ₹7 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Deepak Satija and Rajesh Kumar Goyal.
Its last annual general meeting (AGM) was held on 02 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 397, 2nd Floor Patparganj Industrial Area, Delhi, India – 110092.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.73 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹9.05 Lakh (net margin 1.3%) and EBITDA of ₹26.36 Lakh (EBITDA margin 3.9%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 6% over five years.
The company has about 23 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹45.22 Lakh on record. Court records list 1 case involving the company, including 1 filed against it.
Domagk Smith Laboratories Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-01-0012165). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website domagksmith.com.
Company details
Recognitions & Rankings of Domagk Smith Laboratories
Contact details
Domagk Smith Laboratories Private Limited's registered office is in Delhi, Delhi. Its website is domagksmith.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address397, 2nd Floor Patparganj Industrial Area, Delhi, India – 110092
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Domagk Smith Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Domagk Smith Laboratories is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Domagk Smith Laboratories Private Limited, buy the company report.
Financials of Domagk Smith Laboratories Private Limited
FY 2025 filings availableDomagk Smith Laboratories Private Limited reported revenue of ₹6.73 Cr (up 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 3% growth in the latest year. EBITDA rose 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹26.36 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9.05 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.9% | ||||
| Net Profit Margin | 1.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Domagk Smith Laboratories Private Limited, buy the company report.
Board of directors of Domagk Smith Laboratories Private Limited
Domagk Smith Laboratories has 5 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepak Satija | Director | 25 Jan 2001 | 25 Years 9 Months | Current |
| Rajesh Kumar Goyal | Director | 25 Jan 2001 | 25 Years 9 Months | Current |
| Sunil Batra | Director | 25 Jan 2001 | 25 Years 9 Months | Current |
| Reena Satija | Director | 01 Oct 2006 | 20 Years 1 Months | Current |
| Daya Goyal | Director | 01 Oct 2006 | 20 Years 1 Months | Current |
Peer comparison
Domagk Smith Laboratories Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Newtrimed Healthcare Private Limited | ₹6.79 Cr (FY 2024) | 4.0% | Chennai, Tamil Nadu, India | |||
| Elixir Bio Genics Private Limited | ₹6.74 Cr (FY 2024) | 11.0% | Chennai, Tamil Nadu, India | |||
| Sidhi Vinayak Pharma Private Limited | ₹6.74 Cr (FY 2025) | 33.0% | Delhi, India | |||
| Florid Laboratories Private Limited | ₹6.73 Cr (FY 2025) | 0.0% | Patna, Bihar, India | |||
| Domagk Smith Laboratories Private Limitedthis company | ₹6.73 Cr (FY 2025) | ₹9.05 Lakh | 1.3% | 3.0% | 23 | Delhi, India |
| Merz India Healthcare Private Limited | ₹6.73 Cr (FY 2021) | -63.0% | Dadar East, Maharashtra, India | |||
| Prime Life Science Private Limited | ₹6.72 Cr (FY 2025) | 5.0% | Haryana, India |
To see the full peer comparison of Domagk Smith Laboratories Private Limited, buy the company report.
Auditor
Domagk Smith Laboratories Private Limited is audited by PAWAN CHAGTI AND ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PAWAN CHAGTI AND ASSOCIATES | FY 2023 | 013905N |
Shareholding
The shareholding of Domagk Smith Laboratories Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Domagk Smith Laboratories Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Aug 2023 | 100784981 | Hdfc Bank Limited | ₹15.22 Lakh | Open | |
| 06 Oct 2022 | 100620859 | Hdfc Bank Limited | ₹15 Lakh | Open | |
| 10 Sep 2021 | 100500303 | Hdfc Bank Limited | ₹15 Lakh | Open |
Total charge records: 3 View all charges
Legal cases
Domagk Smith Laboratories Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Kinnaur, Himachal Pradesh | Court case (Motor Vehc Act) | Filed against the company by State of HP | Disposed |
To see the full case history of Domagk Smith Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Domagk Smith Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Domagk Smith Laboratories Private Limited has a workforce of 23 employees on its EPFO records as of Apr 04, 2024, across 1 active EPFO establishment.
GST
Domagk Smith Laboratories has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AABCD7644M1ZD | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Domagk Smith Laboratories Private Limited, buy the company report.
Recent activity
Domagk Smith Laboratories Private Limited has 5 board changes on record since 2001: 5 appointments. The latest: Daya Goyal was appointed as Director on 01 Oct 2006.
Frequently asked questions
Domagk Smith Laboratories is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 January 2001 (25+ years old) and is registered under CIN U74899DL2001PTC109384.
Domagk Smith Laboratories has 5 current directors:
- Deepak Satija - Director
- Rajesh Kumar Goyal - Director
- Sunil Batra - Director
- Reena Satija - Director
- Daya Goyal - Director
The latest financial statements of Domagk Smith Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 02 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Domagk Smith Laboratories is 06AABCD7644M1ZD, registered in Haryana.
The CIN (Corporate Identification Number) of Domagk Smith Laboratories is U74899DL2001PTC109384. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Domagk Smith Laboratories has 1 court case on record: 1 filed against it.
Domagk Smith Laboratories was incorporated on 25 January 2001, making it 25+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Domagk Smith Laboratories by revenue are Newtrimed Healthcare Private Limited, Elixir Bio Genics Private Limited, Sidhi Vinayak Pharma Private Limited, Florid Laboratories Private Limited, Merz India Healthcare Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Daya Goyal was appointed as Director on 01 Oct 2006. Reena Satija was appointed as Director on 01 Oct 2006. Deepak Satija was appointed as Director on 25 Jan 2001. Domagk Smith Laboratories has 5 board changes on record in total.
Yes, Domagk Smith Laboratories is registered as a small enterprise under Udyam registration (number: UDYAM-DL-01-0012165).
Domagk Smith Laboratories can be reached through the website domagksmith.com. Its registered office is in Delhi, India.

